From: Metabolic profiling reveals metabolic features of consolidation therapy in pediatric acute lymphoblastic leukemia
Characteristics
Sex: F/M, N
15/12
Age rage in months, median (IQR)
13–152, 69 (44–132)
Risk group, N (%)a
Standard: 12 (44.4)
Intermediate: 15 (55.6)
MRD46, N (%)b
< 0.01%: 23 (85.2)
≥ 0.01% < 0.1%: 3 (11.1)
> 0.1%: 1 (3.7)